Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Research ArticlePractice

Should weight-loss supplements be used for pediatric obesity?

Alex L. Rogovik and Ran D. Goldman
Canadian Family Physician March 2009; 55 (3) 257-259;
Alex L. Rogovik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ran D. Goldman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rgoldman@cw.bc.ca
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

ABSTRACT

QUESTION In my clinic I have a large population of overweight and obese children. There is a range of weight-loss supplements marketed for the adult population. What natural health products for treatment of obesity are effective and can be used in children?

ANSWER Weight-loss supplements lack sufficient data supporting their efficacy and safety, even in adults. Most weight-loss supplements cannot be recommended at this time for children. Options for obese adolescents include increasing consumption of fibre with diet or using fibre supplements, such as glucomannan. Dietary fibres can also prevent side effects of orlistat, the only medication available for treatment of obese adolescents.

Childhood obesity is one of the most important public health concerns. According to recent estimates from the 2004 Canadian Community Health Survey, 26% of Canadian children and adolescents aged 2 to 17 years are overweight or obese, compared with 15% in 1979,1 and now it is the most common childhood disorder.

Options available for treatment of obesity in children include behavioural and dietary modifications, pharmacotherapy, and weight-loss supplements. Recommended behavioural and dietary modifications include promoting physical activity, limiting “screen time” (ie, watching television or playing video or computer games) to no more than 2 hours a day, and limiting consumption of energy-dense snack foods high in sugar and fat.2 These methods, however, remain largely ineffective because family-oriented behavioural and dietary programs require a great deal of time and effort from the parents, which is not always possible for working families.

Weight-loss supplements

No studies have examined the use of weight-loss supplements other than fibre supplements in children and adolescents. In the United States, however, 11% of adolescents aged 14 to 19 years have used weight-loss supplements in their lifetimes,3 which is comparable to adult use. Sales of weight-loss supplements, the fastest growing segment of the dietary supplement industry, increase at a rate of 10% to 20% per year.4 Supplements are viewed by patients as being natural and are assumed to be safer than prescription drugs. In addition, they represent alternatives to failed attempts at weight loss with the use of more conventional approaches.

Most weight-loss supplements include multiple components, often more than 10. Common ingredients of weight-loss supplements categorized by mechanism of action are presented in Table 1.4

View this table:
  • View inline
  • View popup
Table 1

Common ingredients of weight-loss supplements, categorized by mechanism of action

The majority of weight-loss supplements have not been clearly demonstrated to be either effective or safe, even in adults, and many have been associated with serious adverse events.5 In addition, the multiple components in weight-loss supplements create possibility of interactions, either among ingredients or with concurrently taken medications. Furthermore, many components, such as herbal extracts, contain multiple potentially active ingredients. Even if individual components of a weight-loss product are demonstrated to be safe, the combination of them might not be.6 Many supplements have been found to be contaminated with harmful ingredients7 or mislabeled regarding actual ingredients of the supplement.

Weight-loss supplements are widely advertised and disseminated over the Internet, although many of them have little or no data to support claims and some, such as dinitrophenol, are life-threatening.8 Very few supplements demonstrate clinical efficacy, with no evidence beyond reasonable doubt that any specific dietary supplement is effective for long-term reduction of body weight. Short-term efficacy for adults was demonstrated for ephedra and ephedrine-containing products9; however, since April 2004, their sale has been prohibited in the United States because of concerns about serious adverse events and increased risk of psychiatric, autonomic, or gastrointestinal symptoms and heart palpitations.5 Citrus aurantium—an herb that contains synephrine, a sympathetic α-adrenergic agonist similar to ephedrine—is now commonly used as a substitute for ephedra in weight-loss supplements.10 Bitter orange, however, demonstrated no statistically significant benefit for weight loss (P > .05)10 and, in addition to the adverse effects reported with ephedrine, it can also cause photosensitivity and interact with certain drugs, increasing their concentration.4

There is some evidence of benefit for chromium picolinate, chitosan, conjugated linoleic acid (CLA), hydroxycitric acid, pyruvate, and fibre supplements in adults. Although chromium picolinate appears to have a small weight-reduction effect,11 several cases of rhabdomyolysis or renal failure in patients taking chromium were reported, raising doubts about its safety. There is some evidence that chitosan is more effective than placebo in the short-term treatment of obesity, but results obtained from high-quality trials indicate that the effect of chitosan on body weight is minimal and unlikely to be of clinical significance.12 Conjugated linoleic acid appears to attenuate increases in body weight and body fat in several animal models; however, results from 13 clinical trials in humans found little evidence to show that CLA reduces body weight and suggested that it might have adverse effects on human health via redistribution of fat deposition.13 Several studies performed using Garcinia cambogia in overweight and obese adult subjects are inconsistent and yield conflicting results.14 Although pyruvate has been reported to reduce body fat mass and body fat percentage,15 the evidence is weak.

No studies of weight-loss supplements, other than fibre supplements, in children have been conducted. Intake of dietary fibre is inversely associated with body weight, body fat, and body mass index.16 Its mechanisms for weight reduction include promoting satiation, decreasing absorption of macronutrients, and altering secretion of gut hormones. The average fibre intake in North America is less than half of recommended levels. Although increasing consumption of fibre (eg, fruits, vegetables, whole grains, legumes) with diet is an important step to curb the obesity epidemic, the addition of fibre supplements should also be considered. Glucomannan, a soluble and highly viscous dietary fibre derived from the root of the konjac plant, can promote weight loss in overweight and obese individuals and improve lipid and lipoprotein parameters and glycemic status17 with minimal gastrointestinal side effects. Although little data exist on psyllium for weight reduction, it has been shown to improve glucose homeostasis and the lipid and lipoprotein profile in obese children.18 Inulin (from chicory root) is being sold in many mainstream stores as a fibre supplement, including for use in children; however, its weight-lowering effect has not been studied.

Pharmacotherapy

Pharmacotherapy should be considered for extremely obese children (body mass index ≥ 2 units above the 95th percentile) older than 12 years of age who are resistant to 12-month dietary and lifestyle modifications19; those with marked abdominal adiposity, impaired glucose tolerance or insulin resistance, steatohepatitis, and ovarian hyperandrogenism; and those with strong family history of diabetes, myocardial infarction, or stroke. Orlistat, a fat absorption inhibitor, is the only prescription drug indicated by the Food and Drug Administration for the treatment of overweight adolescents.2 It can cause transient gastrointestinal adverse effects, such as abdominal discomfort, flatulence, and diarrhea, due to unabsorbed fat excreted in the feces.19 However, side effects of orlistat can be prevented by concomitant prescription of dietary fibres.20

Conclusion

Weight-loss supplements lack sufficient data supporting their efficacy and safety, even in adults. Most weight-loss supplements cannot be recommended at this time for children. Options to consider for obese adolescents include increasing consumption of dietary fibre or using fibre supplements. Dietary fibre also prevents side effects of orlistat, the only medication available for treatment of obese adolescents. More research is needed to draw definitive conclusions. No single approach will successfully treat pediatric obesity, and lifestyle modification should be maintained throughout the treatment.

PRETx

Child Health Update is produced by the Pediatric Research in Emergency Therapeutics (PRETx) program at the BC Children’s Hospital in Vancouver, BC. Dr Rogovik is Assistant Director and Dr Goldman is Director of the PRETx program. The mission of the PRETx program is to promote child health through evidence-based research in therapeutics in pediatric emergency medicine.

Do you have questions about the effects of drugs, chemicals, radiation, or infections in children? We invite you to submit them to the PRETx program by fax at 604 875–2414; they will be addressed in future Child Health Updates. Published Child Health Updates are available on the Canadian Family Physician website (www.cfp.ca).

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    ShieldsMMeasured obesity. Overweight Canadian children and adolescentsNutrition: findings from the Canadian Community Health Survey1Ottawa, ONStatistics Canada2005Available from: www.statcan.ca/english/research/82-620-MIE/2005001/pdf/cobesity.pdfAccessed 2008 Jul 11
  2. ↵
    LauDCDouketisJDMorrisonKMHramiakIMSharmaAMUrE2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]CMAJ20071768S113
    OpenUrlFREE Full Text
  3. ↵
    WilsonKMKleinJDSesselbergTSYussmanSMMarkowDBGreenAEUse of complementary medicine and dietary supplements among U.S. adolescentsJ Adolesc Health200638438594
    OpenUrlCrossRefPubMed
  4. ↵
    BartelsCLMillerSJDietary supplements marketed for weight lossNutr Clin Pract200318215669
    OpenUrlFREE Full Text
  5. ↵
    PittlerMHSchmidtKErnstEAdverse events of herbal food supplements for body weight reduction: systematic reviewObes Rev20056293111
    OpenUrlCrossRefPubMed
  6. ↵
    FavreauJTRyuMLBraunsteinGOrshanskyGParkSSCoodyGLSevere hepatotoxicity associated with the dietary supplement LipoKinetixAnn Intern Med200213685905
    OpenUrlCrossRefPubMed
  7. ↵
    BryantSMLozadaCWahlMA Chinese herbal weight loss product adulterated with fenfluramineAnn Emerg Med2005462208
    OpenUrlPubMed
  8. ↵
    HsiaoALSantucciKASeo-MayerPMariappanMRHodsdonMEBanasiakKJPediatric fatality following ingestion of dinitrophenol: postmortem identification of a “dietary supplement”Clin Toxicol20054342815
    OpenUrl
  9. ↵
    ShekellePGHardyMLMortonSCMaglioneMMojicaWASuttorpMJEfficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysisJAMA200328912153745Epub 2003 Mar 10
    OpenUrlCrossRefPubMed
  10. ↵
    BentSPadulaANeuhausJSafety and efficacy of citrus aurantium for weight lossAm J Cardiol20049410135961
    OpenUrlCrossRefPubMed
  11. ↵
    PittlerMHStevinsonCErnstEChromium picolinate for reducing body weight: meta-analysis of randomized trialsInt J Obes Relat Metab Disord20032745229
    OpenUrlCrossRefPubMed
  12. ↵
    Ni MhurchuCDunshea-MooijCABennettDRodgersAChitosan for overweight or obesityCochrane Database Syst Rev20053CD003892
  13. ↵
    LarsenTMToubroSAstrupAEfficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studiesJ Lipid Res20034412223441Epub 2003 Aug 16
    OpenUrlAbstract/FREE Full Text
  14. ↵
    HeymsfieldSBAronneLJBlackburnGLHCA efficiencyDiabetes Obes Metab2004664589
    OpenUrlPubMed
  15. ↵
    PittlerMHErnstEDietary supplements for body-weight reduction: a systematic reviewAm J Clin Nutr200479452936
    OpenUrlAbstract/FREE Full Text
  16. ↵
    SlavinJLDietary fiber and body weightNutrition20052134118
    OpenUrlCrossRefPubMed
  17. ↵
    KeithleyJSwansonBGlucomannan and obesity: a critical reviewAltern Ther Health Med2005116304
    OpenUrlPubMed
  18. ↵
    MorenoLATresacoBBuenoGFletaJRodriguezGGaragorriJMPsyllium fibre and the metabolic control of obese children and adolescentsJ Physiol Biochem200359323542
    OpenUrlCrossRefPubMed
  19. ↵
    DunicanKCDesiletsARMontalbanoJKPharmacotherapeutic options for overweight adolescentsAnn Pharmacother2007419144555Epub 2007 Jul 24
    OpenUrlCrossRefPubMed
  20. ↵
    CavaliereHFlorianoIMedeiros-NetoGGastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid)Int J Obes Relat Metab Disord200125710959
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 55 (3)
Canadian Family Physician
Vol. 55, Issue 3
1 Mar 2009
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Should weight-loss supplements be used for pediatric obesity?
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Should weight-loss supplements be used for pediatric obesity?
Alex L. Rogovik, Ran D. Goldman
Canadian Family Physician Mar 2009, 55 (3) 257-259;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Should weight-loss supplements be used for pediatric obesity?
Alex L. Rogovik, Ran D. Goldman
Canadian Family Physician Mar 2009, 55 (3) 257-259;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Weight-loss supplements
    • Pharmacotherapy
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Effectiveness of dermoscopy in skin cancer diagnosis
  • Spontaneous pneumothorax in children
  • Is 45 the new 50 in colorectal cancer screening?
Show more Practice

Child Health Update

  • Accidental cannabis ingestion in young children
  • All-terrain vehicle injuries in children and adolescents
  • Screen time and sleep in children
Show more Child Health Update

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire